Form 4: Quest Diagnostics Director Acquires Shares

Quest Diagnostics Director Timothy L. Main acquired 1,142 shares of common stock.

Summary

• Timothy L. Main, a Director at Quest Diagnostics Inc., acquired 1,142 shares of common stock on May 20, 2026.
• The acquisition was made at a price of $0 per share, indicating it was likely an award or grant.
• Following this transaction, Mr. Main beneficially owns 27,439 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine stock acquisition by a director, which does not provide new financial performance data or strategic insights.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 1,142 shares by a director is a direct increase in beneficial ownership.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it is a statement of changes in beneficial ownership.

Industry Context

StockSavvy.ai notes that director stock acquisitions, while not directly indicative of company performance, can be interpreted by the market as a positive signal of insider confidence in the company's valuation and future prospects within the healthcare diagnostics sector.

Stakeholder Impact

• Shareholders: May view the director's acquisition as a positive signal of confidence in the company's stock.
• Management: The transaction reflects standard insider reporting procedures.

Key Dates

Keywords

Quest Diagnostics, DGX, Form 4, Insider Trading, Director, Stock Acquisition, Beneficial Ownership